A couple of weeks ago, the 𝐑𝐞𝐣𝐮𝐯𝐞𝐫𝐬𝐞𝐧 𝐭𝐞𝐚𝐦 celebrated our 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐥𝐮𝐧𝐜𝐡 at a fantastic restaurant in the heart of Barcelona. They say the best conversations happen around a table with great food—and we couldn’t agree more! 🍴✨ Just as important as running experiments is 𝐭𝐚𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐭𝐢𝐦𝐞 𝐭𝐨 𝐝𝐢𝐬𝐜𝐮𝐬𝐬 results, 𝐬𝐡𝐚𝐫𝐞 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐩𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞𝐬, and 𝐛𝐫𝐚𝐢𝐧𝐬𝐭𝐨𝐫𝐦 𝐟𝐮𝐭𝐮𝐫𝐞 𝐝𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧𝐬. That’s exactly what we did throughout the afternoon. Since then, our R&D team has been working nonstop, finalizing experiments before the holidays to hit the milestones we set at the beginning of the year. After all, 𝐬𝐞𝐧𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐭𝐚𝐤𝐞 𝐚 𝐛𝐫𝐞𝐚𝐤, 𝐚𝐧𝐝 𝐧𝐞𝐢𝐭𝐡𝐞𝐫 𝐝𝐨 𝐰𝐞! 🚀 We’ve also had 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐞 𝐦𝐞𝐞𝐭𝐢𝐧𝐠𝐬 𝐭𝐨 𝐜𝐡𝐞𝐜𝐤 𝐨𝐟𝐟 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐝 𝐠𝐨𝐚𝐥𝐬 and start shaping the objectives for the year ahead. For 𝟐𝟎𝟐𝟓, we’re 𝐡𝐨𝐩𝐢𝐧𝐠 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞, 𝐦𝐨𝐫𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐚𝐧𝐝 𝐦𝐨𝐫𝐞 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬. 𝐖𝐢𝐬𝐡𝐢𝐧𝐠 𝐲𝐨𝐮 𝐚𝐥𝐥 𝐚 𝐯𝐞𝐫𝐲 𝐌𝐞𝐫𝐫𝐲 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐚𝐧𝐝 𝐚 𝐇𝐚𝐩𝐩𝐲 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫!🎄✨ #Teamwork #Innovation #ResearchAndDevelopment #HealthyAging #Biotech #PharmaIndustry #ResearchGoals #NewYear2025
Rejuversen
Biotechnologieforschung
Discovering and developing novel therapies for diseases driven by senescence
Info
Rejuversen (formerly Rejuveron Senescence Therapeutics) is a biotech company developing novel medicines that target senescence in age-related diseases associated with fibrosis and in oncology
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Art
- Privatunternehmen
- Gegründet
- 2020
Beschäftigte von Rejuversen
Updates
-
Excited to announce that Rejuversen has been selected as a semi-finalist in EIT Health´s Catapult program!
📢 Exciting News! EIT Health Catapult 2024-25 Semi-Finalists Announced! We’re thrilled to unveil the 29 groundbreaking start-ups selected for the semi-finals of the 9th edition of the EIT Health Catapult! They are: Aptadel Therapeutics, ArrayPatch Ltd, Cellectric Biosciences, Fusix Biotech GmbH, Immunofusion, Nūmi, PepKon, PoliRNA, Rejuversen, You2Yourself, Antegenes, BrightComSol, Brightmind.AI, CC Diagnostics, CheckEye, cureVision GmbH, Custom Surgical, FindAir, Galenband, Healshape, Kinetic Cortex, Lifebloom, mjn-neuro, NimBio, NIMBLE Diagnostics, PsyCurio, The Blue Box Biomedical Solutions, Tympany Medical , and VitalSigns Oy. These innovators, spanning life sciences and healthtech, are set to showcase their life-changing solutions to top industry experts, investors, and peers from across Europe. ✨ Key Highlights: - Semi-Final Presentations: 10 Life Sciences & 19 Healthtech start-ups will present to a public audience of healthcare professionals, investors, and experts. - Finals Announcement in April 2025: Top 9 start-ups (3 Life Sciences & 6 Healthtech) will advance to the finals, competing for a €30,000 prize and valuable in-kind support. - Major Prizes: Industry in-kind prizes totaling over €800,000 from top names like Amazon Web Services (AWS), eg technology Ltd, Lusíadas Saúde, AstraZeneca, and the prestigious "EIT Health Catapult Audience Alex Casta Award" 🏆 🎉 The EIT Health Catapult programme has a legacy of empowering start-ups with high-impact mentorship, rigorous business assessment, and unparalleled networking opportunities. Over eight editions, Catapult has supported 330+ companies in securing multi-million euro investments and vital support from key European partners. 👉 Stay tuned as these start-ups push boundaries, inspire change, and compete for Europe’s spotlight in healthcare innovation: https://lnkd.in/eudWYHEj #EITHealthCatapult #HealthcareInnovation #LifeSciences #Healthtech #StartUps
-
#Rejuversen has been selected as a regional finalist in the EIT Health Catapult program pitch competition! We are looking forward to seeing our fellow biotechs and jury panel at the event next week in Santander!
🚀 EIT Health's Catapult es la competición de EIT Health donde las mejores startups sanitarias se dan citan. 📅 El próximo 9 de octubre y dentro del EIT Health Matchmaking que tendrá lugar en Santander, será la final regional de Catapult en el que 7 startups de EIT Health Spain harán su pitch. 3 de ellas pasarán a la semifinal europea. A continuación las startups: 🔸 NIMBLE Diagnostics con Oriol Iborra Egea, PhD 🔸 Biel Glasses con Jaume Puig Adamuz 🔸 The Blue Box Biomedical Solutions con Judit Giró Benet 🔸mjn-neuro con Jordina Arcal Cunillera 🔸 Clinicgram con Ibon Uribe 🔸Aptadel Therapeutics con Gisela Lorente 🔸Rejuversen con Timothy Cash 👀 Tendremos un Jurado de excepción con: 🔸 César Velasco Muñoz de AstraZeneca 🔸 Maite Fibla Gasparin, PhD de Ship2B Ventures 🔸 Cinta Díez, PhD de Invivo Partners 🔸 Sergio San Agustín de Clave Capital 🔸 Javier Colás Fustero de Additum Blockchain - Creando Valor en Salud ⏳ Os esperamos en Santander para conocer las startups que revolucionarán la salud. Con el apoyo de AstraZeneca Amazon Web Services (AWS) eg technology Ltd Lusíadas Saúde Nasdaq
-
-
An excellent day of discussion and networking with top notch drug hunters and developers from biotech and Pharma!
𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐧𝐞𝐬𝐜𝐞𝐧𝐜𝐞 𝐚𝐬 𝐚 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐭𝐚𝐫𝐠𝐞𝐭 𝐢𝐧 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐚𝐠𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 by Our eminent speaker, Timothy Cash CSO Rejuversen #ddip #day1 #conference #drugdiscovery #innovation #programme #worldbi #event #ddip2k24
-
-
Excited to be presenting the latest on our programs on targeting senescence in fibrosis and oncology this week in Barcelona at the DDIP conference!
𝑻𝒂𝒌𝒆 𝒂 𝑺𝒏𝒆𝒂𝒌 𝑷𝒆𝒆𝒌 𝒊𝒏𝒕𝒐 𝑻𝒉𝒊𝒔 𝑪𝒂𝒑𝒕𝒊𝒗𝒂𝒕𝒊𝒏𝒈 𝑷𝒓𝒆𝒔𝒆𝒏𝒕𝒂𝒕𝒊𝒐𝒏 𝑻𝒐𝒑𝒊𝒄! 𝑶𝒖𝒓 𝑬𝒙𝒑𝒆𝒓𝒕, Timothy Cash 𝒘𝒊𝒍𝒍 𝑷𝒓𝒆𝒔𝒆𝒏𝒕 𝒕𝒉𝒆 𝒕𝒐𝒑𝒊𝒄 𝒐𝒏 𝑫𝒂𝒚 1: 𝑺𝒆𝒏𝒆𝒔𝒄𝒆𝒏𝒄𝒆 𝒂𝒔 𝒂 𝒕𝒉𝒆𝒓𝒂𝒑𝒆𝒖𝒕𝒊𝒄 𝒕𝒂𝒓𝒈𝒆𝒕 𝒊𝒏 𝒐𝒏𝒄𝒐𝒍𝒐𝒈𝒚 𝒂𝒏𝒅 𝒂𝒈𝒆-𝒓𝒆𝒍𝒂𝒕𝒆𝒅 𝒅𝒊𝒔𝒆𝒂𝒔𝒆𝒔. 𝑫𝒐𝒏’𝒕 𝒎𝒊𝒔𝒔 𝒕𝒉𝒊𝒔 𝒎𝒖𝒔𝒕-𝒂𝒕𝒕𝒆𝒏𝒅 𝒔𝒆𝒔𝒔𝒊𝒐𝒏! 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐍𝐨𝐰: https://bit.ly/3xEKWRT #drugdiscovery #drugdiscovery #innovation #genomics #toxicology #structuralbiology #drugdiscoveryconference #ddipeu #worldbievent #scienceresearch #ddip24 | Rejuversen
-
-
🌟The Rejuversen team is thrilled to be in Copenhagen for ARDD 2024 this week! 🚀 We’re excited to showcase the latest innovations of our scientists Alex Cordero Casanovas and Marc Antoni Armengol i Cubillos, PhD. and connect with industry leaders in drug discovery and aging. Our team is looking forward to engaging in insightful discussions, exploring cutting-edge research, and discovering new opportunities for collaboration. If you’re at the conference, don’t hesitate to reach out—let’s connect and drive the future of aging and drug discovery together! #ARDD2024 #Rejuversen #DrugDiscovery #aging #Networking #innovation #senescence
-
Rejuversen hat dies direkt geteilt
𝑺𝒕𝒆𝒑 𝒊𝒏𝒕𝒐 𝒕𝒉𝒆 𝒘𝒐𝒓𝒍𝒅 𝒐𝒇 𝒄𝒖𝒕𝒕𝒊𝒏𝒈-𝒆𝒅𝒈𝒆 𝒑𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 at the 24th Drug Discovery Innovation Programme, 𝒘𝒉𝒆𝒓𝒆 𝒘𝒆 𝒑𝒓𝒐𝒖𝒅𝒍𝒚 𝒑𝒓𝒆𝒔𝒆𝒏𝒕 𝒂𝒏 𝒆𝒙𝒄𝒆𝒑𝒕𝒊𝒐𝒏𝒂𝒍 𝒍𝒊𝒏𝒆𝒖𝒑 𝒐𝒇 𝒈𝒖𝒆𝒔𝒕 𝒔𝒑𝒆𝒂𝒌𝒆𝒓𝒔 𝒂𝒏𝒅 𝒅𝒊𝒔𝒕𝒊𝒏𝒈𝒖𝒊𝒔𝒉𝒆𝒅 𝒔𝒑𝒐𝒏𝒔𝒐𝒓𝒔. Each speaker brings profound insights and expertise, guiding us through the latest advancements and future trends in drug discovery. Our sponsors, renowned leaders in the industry, stand alongside us in advancing healthcare through their invaluable support and collaboration. 𝑱𝒐𝒊𝒏 𝒖𝒔 𝒇𝒐𝒓 𝒂𝒏 𝒊𝒏𝒔𝒑𝒊𝒓𝒊𝒏𝒈 𝒈𝒂𝒕𝒉𝒆𝒓𝒊𝒏𝒈 𝒘𝒉𝒆𝒓𝒆 𝒌𝒏𝒐𝒘𝒍𝒆𝒅𝒈𝒆 𝒎𝒆𝒆𝒕𝒔 𝒐𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒚, 𝒔𝒉𝒂𝒑𝒊𝒏𝒈 𝒕𝒉𝒆 𝒇𝒖𝒕𝒖𝒓𝒆 𝒐𝒇 𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆 𝒕𝒐𝒈𝒆𝒕𝒉𝒆𝒓. #leadership #drugdiscovery #innovation #genomics #sciencestudent #steam #scientist #biologics #medicinalchem #drugdiscovery #oncology #drugdiscoveryconference #ddipeu #worldbievents #scienceresearch #ddip24 Soroush Safaei | Sanofi | Gabriele Magaro' | Rudi Schmidt | Institute for Healthier Living Abu Dhabi | Claude Bertrand | Servier | Johan Luthman | Lundbeck | Davide Gianni | AstraZeneca | Claudio Hidalgo Cantabrana | Microviable Therapeutics SL | Alex Alderton | Dr. Rafik FELLAGUE-CHEBRA, MD, MSc | Novartis Oncology | DAVID MORENO DELGADO | Galapagos | Juan Basterra | Mikrobiomik | Konstantinos Gkatzis, PhD | Ksilink | Jekaterina Kaliniene, EMBA | Innovation Agency Lithuania | Global | Maria Loustau | Invectys | Neelima Khairatkar-Joshi | Eric Scheinbart M.D. | Dr. Devendra Ridhurkar | Fred Manby | Iambic Therapeutics | Timothy Cash | Rejuversen
-
-
Rejuversen hat dies direkt geteilt
📍 The Catalan delegation at #BIO2024 in San Diego will include 37 companies and entities from the #biotechnology sector based in Catalonia, representing more than 40% of the Spanish delegation. Come and meet them! You will find some of these companies at the Spain Pavilion #3424 (coordinated by ICEX) or at the #1511 Europe Pavilion alongside with other European biotechnology companies, academic institutions and stakeholders. Are you willing to know further the biotechnology ecosystems in the US and Catalonia❓ ⏰ Join the Catalonia BioNetworking Event on June 3, from 6:00 pm to 7:30 pm. A side event (organized by The Government of Catalonia, ACCIÓ, and #Biocat) for companies and organizations willing to create synergies, share knowledge, and better understand the #biotechnology ecosystems of North America and #Catalonia. Sign up! 👉 https://tuit.cat/c925S
-